- Press Release
- September 24, 2022
Nanoracks Italia and Kayser Italia Announce Agreement to Open Temperature Controlled Microgravity Research on International Space Station
Nanoracks Space Outpost – Europe (Nanoracks Italia) and Kayser Italia have announced today that the organizations have sign an agreement to broaden research opportunities onboard the International Space Station which leverage the Bioreactor Express Service.
Kayser Italia, in partnership with the European Space Agency, will have access to the KUBIK Incubator, under the Bioreactor Express Service partnership agreement. KUBIK is a small controlled-temperature incubator or cooler with removable inserts designed for self-contained microgravity experiments. On board the Space Station since 2004, KUBIK has hosted numerous extensive microgravity biology and biochemistry experiments.
KUBIK allows experiments to operate in the range of 6°C to 38°C. A centrifuge with settable gravity level between 0.2g to 2g is available inside the facility as well. Additional specifications of the platform can be found here.
“We are very excited to expand the microgravity research opportunities we can offer our customers,” says Nanoracks Italia Director of Global Engagement, Veronica La Regina. “Our customers want temperature control, and now we have it. Access to KUBIK will open up new venues to develop extensive commercial utilization of the Space Station.”
This agreement allows Nanoracks Italia to continue expanding commercial access to the Space Station at affordable prices and conditions, to new customers from new market sectors participating LEO economy.
In the framework of this agreement, Kayser Italia will also be able to provide a wide set of flight proven experiment hardware, including bioreactors and containers, to make access to the hardware easier for the customer. KUBIK of course can also handle customized customer hardware, so long as it meets interface requirements.
“Kayser Italia track record in designing, building and operating experiments onboard the ISS has led to the development of this commercial initiative.” says Kayser Italia CEO, David Zolesi. “With Bioreactor Express Service, we want to make KUBIK accessible to everyone, providing an end-to-end service from concept to implementation, for a reasonable price and within an acceptable time-frame.”
If you are interested in learning more about this research opportunity, please be sure to visit:
• Nanoracks at Booth #207 at IAC 2019, or send a note at email@example.com
• Kayser Italia at Booth #283 at IAC 2019, or send a note at firstname.lastname@example.org